1. Home
  2. EMBC vs PFLT Comparison

EMBC vs PFLT Comparison

Compare EMBC & PFLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Embecta Corp.

EMBC

Embecta Corp.

HOLD

Current Price

$10.11

Market Cap

602.3M

Sector

Health Care

ML Signal

HOLD

Logo PennantPark Floating Rate Capital Ltd.

PFLT

PennantPark Floating Rate Capital Ltd.

HOLD

Current Price

$8.68

Market Cap

899.9M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
EMBC
PFLT
Founded
1924
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
602.3M
899.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
EMBC
PFLT
Price
$10.11
$8.68
Analyst Decision
Buy
Buy
Analyst Count
2
6
Target Price
$18.50
$10.67
AVG Volume (30 Days)
878.3K
1.2M
Earning Date
02-05-2026
02-09-2026
Dividend Yield
5.90%
14.25%
EPS Growth
138.19
N/A
EPS
2.36
0.36
Revenue
$1,079,700,000.00
$264,507,000.00
Revenue This Year
$2.00
$11.75
Revenue Next Year
$0.27
N/A
P/E Ratio
$4.31
$24.28
Revenue Growth
N/A
22.80
52 Week Low
$9.20
$8.40
52 Week High
$16.76
$11.46

Technical Indicators

Market Signals
Indicator
EMBC
PFLT
Relative Strength Index (RSI) 37.85 28.38
Support Level $9.93 $9.27
Resistance Level $10.39 $9.52
Average True Range (ATR) 0.71 0.19
MACD -0.05 -0.09
Stochastic Oscillator 7.36 0.00

Price Performance

Historical Comparison
EMBC
PFLT

About EMBC Embecta Corp.

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

About PFLT PennantPark Floating Rate Capital Ltd.

PennantPark Floating Rate Capital Ltd is a closed-end, externally managed, non-diversified investment company. Its investment objectives are to generate both current income and capital appreciation by investing in Floating Rate Loans and other investments made to U.S. middle-market companies. The company believes that Floating Rate Loans to U.S. middle-market companies offer attractive risk-reward to investors due to the limited amount of capital available for such companies and the potential for rising interest rates. The company generates revenue in the form of interest income on the debt securities and dividends.

Share on Social Networks: